Hot Low Price Stocks To Watch For 2015

It really shouldn't matter a lick what price a stock is trading at. There is no fundamental difference between a stock with 1 million shares trading at $50 and a stock with 10 million shares trading at $5.

Then again, there are people whose interest is piqued when they see a low price tag. It's one of the reasons why many companies will split their stock. The lower price tag will sometimes entice more buying.

 

When you consider the rule of large numbers, the phenomenon of lower-priced stocks rising faster than their higher-priced brethren does make a little sense. After all, for a stock trading at $5 to gain 50%, it has to only rise $2.50. But for a $100 stock, the same move takes $50.

Investors aren't always rational, and that $2.50 move seems a lot smaller than a $50 rise, even though they are the exact same in percentage terms.

Hot Low Price Stocks To Watch For 2015: The Medicines Company(MDCO)

The Medicines Company, a pharmaceutical company, provides various medicines to hospitals for advancing the treatment of critical care patients worldwide. The company markets Angiomax, an intravenous direct thrombin inhibitor for use as an anticoagulant in combination with aspirin in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty and for use in patients undergoing percutaneous coronary intervention; and Cleviprex, an intravenous small molecule calcium channel blocker for the reduction of blood pressure, as well as to treat neurocritical care and cardiac surgery patients. Its products under development include Cangrelor that is in Phase III clinical trial acts as an intravenous small molecule antiplatelet agent to prevent platelet activation and aggregation; and Oritavancin, which is in Phase III clinical trial acts as an investigational intravenous antibiotic for the treatment of serious gram-positive bacterial infections, including acute bacterial skin and skin structure infections. The company?s products under development also comprise MDCO-157, a pre-registration stage product for platelet inhibition in patients suffering from acute coronary syndrome (ACS), and patients experiencing myocardial infarction, stroke, or peripheral arterial disease; MDCO-2010, a small molecule serine protease inhibitor that is in Phase II clinical trial used for the reduction of blood loss during surgery; and MDCO-216, which is in Phase I clinical trial used for the reversal of atherosclerotic plaque development and the reduction of the risk of coronary events in patients with ACS. Its products also consist of Argatroban, a direct thrombin inhibitor used as anticoagulant for prophylaxis or for the treatment of thrombosis; and acute care generic products. The Medicines Company was founded in 1996 and is based in Parsippany, New Jersey.

Advisors' Opinion:

• [By Lisa Levin]

  The Medicines Company (NASDAQ: MDCO) shares touched a new 52-week low of $24.17 after the company provided an update on Angiomax patent litigation.

• [By Jake L'Ecuyer]

  Equities Trading DOWN
  Shares of The Medicines Company (NASDAQ: MDCO) were down 14.64 percent to $24.26 after the company provided an update on Angiomax patent litigation.

Hot Low Price Stocks To Watch For 2015: Amsurg Corp.(AMSG)

AmSurg Corp., through its wholly owned subsidiaries, engages in the development, acquisition, and operation of ambulatory surgery centers in partnership with physicians in the United States. The company?s surgery centers perform colonoscopy and other endoscopy procedures in the area of gastroenterology; cataracts and retinal laser surgery in the area of ophthalmology; and knee and shoulder arthroscopy and carpal tunnel repair in the area of orthopedics. As of December 31, 2010, it owned interest in 204 surgery centers in 33 states and the District of Columbia, including 140 centers performed gastrointestinal endoscopy procedures, 37 centers performed ophthalmology surgery procedures, 19 centers were multiple specialties, and 8 centers performed orthopaedic procedures. AmSurg Corp. markets its surgery centers directly to patients; and referring physicians and third-party payors, such as health maintenance organizations, preferred provider organizations, other managed care o rganizations, and employers. The company was founded in 1992 and is headquartered in Nashville, Tennessee.

Advisors' Opinion:

• [By Tom Lydon]

  Top holdings based on the index include Acadia Healthcare Companies (ACHC), Amsurg Corporation (AMSG), Brookdale Senior Living (BKD), Clarcor (CLC) and Community Health Systems (CYH).

• [By John Reese]

  Indeed, in 2013, the Greenblatt-based portfolio has bounced back strong, returning more than 50%. Below is a look at its current holdings.

  EBIX, Inc. (EBIX)
  
  Western Refining (WNR)
  
  DirecTV (DTV)
  
  ITT Educational Services (ESI)
  
  Science Applications International (SAIC)
  
  Weight Watchers International (WTW)
  
  ConocoPhillips (COP)
  
  AmSurg Corp. (AMSG)
  
  PDL BioPharma (PDLI)
  
  AFC Enterprises (AFCE)
  
  

  Subscribe to Validea here��/p>

Top Clean Energy Companies To Watch In Right Now: Cooper Companies Inc (COO)

The Cooper Companies, Inc., incorporated on March 4, 1980, is a global medical device company. The Company operates through two business units, CooperVision, Inc. and CooperSurgical, Inc. CooperVision is a global manufacturer providing products for contact lens wearers. CooperSurgical focuses on supplying women's health clinicians with products and treatment options to improve the delivery of healthcare to women.

CooperVision develops, manufactures and markets a range of monthly, two-week and single-use contact lenses, featuring advanced materials and optics. CooperVision's products are designed to solve vision challenges such as astigmatism, presbyopia and ocular dryness with a collection of spherical, toric and multifocal contact lenses. CooperVision's products are primarily manufactured at its facilities located in Hampshire, United Kingdom, Juana Diaz, Puerto Rico, and Scottsville, New York. CooperVision distributes products from West Henrietta, New York, Fareham, United Kingdom, Liege, Belgium, and various smaller international distribution facilities. Under the Biofinity brand, CooperVision has launched monthly silicone hydrogel spherical, toric and multifocal lens products. CooperVision has also launched two-week silicone hydrogel spherical and toric lens products under its Avaira brand. During the fiscal year ended October 31, 2013 (fiscal 2013), the Company launched MyDay, its single-use spherical silicone hydrogel lens, in Europe. CooperVision's Proclear line of spherical, toric and multifocal lenses are manufactured with omafilcon, a material that incorporates Phosphorylcholine (PC) Technology that helps enhance tissue-device compatibility.

CooperSurgical offers an array of products used in the care and treatment of women's health. The Company participates in the women's healthcare market through offering quality products, technologies and service to clinicians worldwide. CooperSurgical collaborates with clinicians to identify products and new technologies from dis! posable products to instruments and equipment. The result is a portfolio of products that aid in the delivery of improved clinical outcomes that healthcare professionals use routinely in the diagnosis and treatment of a wide spectrum of women's health issues.

The Company competes with Johnson & Johnson Vision Care, Inc., CIBA Vision, Bausch & Lomb Incorporated, Boston Scientific, Johnson & Johnson's Ethicon Endo-Surgery and Ethicon Women's Health and Urology companies, Gyrus ACMI and Covidien.

Advisors' Opinion:

• [By John Kell and Lauren Pollock var popups = dojo.query(".socialByline .popC"); ]

  Cooper Cos.(COO) said its revenue jumped more than 6% in its fiscal first quarter, though its profit still fell as result of higher costs and expenses.

Hot Low Price Stocks To Watch For 2015: ThyssenKrupp AG (TKA)

ThyssenKrupp AG is a Germany-based technology holding company operating in seven business areas. The Steel Europe division produces carbon steel flat products. The Steel Americas division is engaged in production, processing and marketing of high-grade carbon steels. The Materials Services division is engaged in global distribution of materials and the provision of complex technical services for the production and manufacturing sectors. The Elevator Technology division is engaged in the area of passenger transportation systems. The Plant Technology division focuses on specialty and large-scale plant construction. The Components Technology division is engaged in manufacturing components for the automotive, construction and engineering sectors as well as for wind turbines. The Marine Systems division focuses on naval and civil shipbuilding. Apart from its business areas, it provides business services, which are diversified into Business Services and Information Technology (IT) Services. Advisors' Opinion:

• [By Sofia Horta e Costa]

  ThyssenKrupp AG (TKA), Germany�� largest steelmaker, rose to a five-week high. YOC AG (YOC) surged the most in more than three months after the mobile-phone advertising company said it sold 1.3 million euros ($1.7 million) of shares to increase capital. Lanxess AG (LXS), the chemical maker that joined the DAX in September, retreated 3.4 percent.

• [By Corinne Gretler]

  Telekom Austria (TKA) slid 1.6 percent to 5.63 euros. Second-quarter earnings before interest, taxes, depreciation and amortization fell to 330.3 million euros ($439 million) from 364.8 million euros a year earlier. That compared with the average 332.7 million-euro analyst estimate.

• [By Corinne Gretler]

  ThyssenKrupp AG (TKA) slumped 9.3 percent after Germany�� largest steelmaker raised 882.3 million euros ($1.21 billion) through a share sale. Standard Chartered Plc lost 8.1 percent. Sage Group (SGE) Plc, the U.K.�� biggest software maker, rose 6.8 percent after reporting revenue growth that exceeded analysts��estimates. AZ Electronic Materials SA surged 43 percent after Merck KGaA (MRK) agreed to buy it for about 1.6 billion pounds ($2.6 billion).

Hot Low Price Stocks To Watch For 2015: The Dixie Group Inc.(DXYN)

The Dixie Group, Inc. engages in the manufacture, marketing, and sale of carpets and rugs to residential and commercial customers primarily in the United States. It also offers broadloom and modular carpets for the specified commercial marketplace. The company sells its products under the Fabrica International, Masland Carpets, and the Dixie Home brands. It also processes yarns, and provides carpet dyeing and finishing services to other carpet manufacturers. The company primarily serves interior decorators and designers, selected retailers and furniture stores, luxury home builders, and manufacturers of luxury motor coaches and yachts. The Dixie Group, Inc. was founded in 1920 and is based in Chattanooga, Tennessee.

Advisors' Opinion:

• [By Roberto Pedone]

  Dixie Group (DXYN) markets, manufactures and sells carpet and rugs to high-end residential and commercial customers through its various sales forces and brands. This stock closed up 10.9% at $11.48 in Thursday's trading session.

  Thursday's Volume: 218,000
  
  Three-Month Average Volume: 82,425
  
  Volume % Change: 198%

  From a technical perspective, DXYN ripped sharply higher here right above some near-term support around $10 with strong upside volume. This stock has been trending sideways inside of a consolidation pattern for the last month, with shares trending between $10 on the downside and $12.05 on the upside. This consolidation pattern is occurring after a strong uptrend for shares of DXYN, which took the stock from $4.99 in March to $10 in August. This spike is now starting to push shares of DXYN within range of triggering a big breakout trade. That trade will hit if DXYN manages to take out Thursday's intraday high at $11.99 and then once it clears its 52-week high at $12.05 with high volume.

  Traders should now look for long-biased trades in DXYN as long as it's trending above $11 or Thursday's low of $10.43, and then once it sustains a move or close above those breakout levels with volume that hits near or above 82,425 shares. If that breakout triggers soon, then DXYN will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $15 to $16.

• [By David Goodboy]

  The company I discovered astounded me: It's up more than 220% in the past year, and shares are trading for around $11. It is high-end carpet maker The Dixie Group (Nasdaq: DXYN). Founded in 1919, this carpet manufacturer and marketing company has a market cap of about $143 million and annual revenue of just over $296 million. It sells carpets with the Fabrica International, Masland Residential and Dixie Home brands. 

Hot Low Price Stocks To Watch For 2015: Ryanair (RYAAY)

Ryanair Holdings plc (Ryanair Holdings), incorporated in 1996, is a holding company for Ryanair Limited (Ryanair). Ryanair operates a low-cost, scheduled-passenger airline serving short-haul, point-to-point routes between Ireland, the United Kingdom, Continental Europe, and Morocco. As of June 30, 2012, the Company offered approximately over 1,500 scheduled short-haul flights per day serving approximately 160 airports largely throughout Europe with an operating fleet of 294 aircraft flying approximately 1,500 routes. Ryanair sells seats on a one-way basis. The Company also holds a 29.8% interest in Aer Lingus Group plc. As of June 30, 2012, Ryanair�� operating fleet was composed of 294 Boeing 737-800 aircraft, each having 189 seats. Ryanair�� fleet totaled 294 Boeing 737-800s at March 31, 2012. As of June 30, 2012, Ryanair owned and operated four Boeing 737-800 full flight simulators for pilot training. Ryanair provides ancillary services and engages in other activities connected with its core air passenger service, including non-flight scheduled services, Internet-related services, and the in-flight sale of beverages, food, and merchandise. As part of its non-flight scheduled and Internet-related services Ryanair incentivizes ground service providers at airports it serves to levy correct excess baggage charges for any baggage, which exceeds Ryanair�� published baggage allowances. Excess baggage charges are recorded as non-flight scheduled revenue. Ryanair distributes accommodation services and travel insurance through its Website. For hotel services, Ryanair has a contract with Hotelscombined PTY Ltd. (Hotelscombined), which operates a price comparison Website, pursuant to which Hotelscombined handles all aspects of such services marketed through Ryanair�� Website and pays a fee to Ryanair. Ryanair also has contracts with other accommodation providers that enable Ryanair to offer hostel, bed-and-breakfast, guesthouse, villa and apartment accommodation to its customers. In addition Ryanair has a contract with Hertz, pursuant to which Hertz handles all car rental services marketed through Ryanair�� Website or telephone reservation system. Ryanair also sells bus and rail tickets onboard its aircraft and through its Website. Ryanair also sells attractions and activities on its Website. Ryanair sells gift vouchers on its Website, which are also redeemable online. The Company has an contract with Webloyalty International Ltd, which offers Ryanair�� customers who have a United Kingdom, German or French billing address a retail discount and cash-back program. Ryanair has agreements, pursuant to which the Company promotes Ryanair-branded credit cards issued by MBNA, GE Money, Access Prepaid and Banco Santander on its Internet site. The MBNA agreement relates to Irish residents only, the GE Money agreement relates to Swedish and Polish residents only and the Banco Santander agreement relates to United Kingdom residents only. During the fiscal year ended March 31, 2012, Ryanair rolled out handheld Electronic Point of Sale (EPOS) devices across its route network. These EPOS devices replaced manual and paper based systems on board the aircraft. The EPOS device enables cabin crew to sell and record their on-board sales transactions. The EPOS device also issues bus and rail tickets and tickets for tourist attractions. The Company also offers reserved seating in twenty-one extra legroom seats on each aircraft for a fee on certain routes. Ryanair provides its own aircraft and passenger handling and ticketing services at Dublin Airport. Third parties provide these services to Ryanair at other airports it serves. Servisair plc provides Ryanair�� ticketing, passenger and aircraft handling, and ground handling services at airports in Ireland and the United Kingdom(excluding London (Stansted) Airport where these services are provided by Swissport Ltd.), while similar services in continental Europe are provided by the local airport authorities, either directly or through sub-contractors. Advisors' Opinion:

• [By Jake L'Ecuyer]

  Equities Trading UP
  Ryanair Holdings plc (NASDAQ: RYAAY) shares shot up 6.55 percent to $54.32 after the company reported full-year results. Ryanair's net profit for the year ended March 31 slipped to 522.8 million euros ($716 million), versus a year-ago profit of EUR569.3 million.

• [By Monica Gerson]

  Ryanair Holdings plc (NASDAQ: RYAAY) dipped 4.09% to $49.43 in pre-market trading after falling 1.06% on Thursday.

  Posted-In: PreMarket LosersNews Movers & Shakers Pre-Market Outlook Markets

Hot Low Price Stocks To Watch For 2015: Amarin Corporation PLC(AMRN)

Amarin Corporation Plc, a clinical-stage biopharmaceutical company, focuses on developing treatments for cardiovascular diseases. Its lead product candidate includes AMR101, a prescription grade omega-3 fatty acid, which is in second Phase III clinical trial for the treatment of high triglyceride levels in statin-treated patients who have mixed dyslipidemia. The company, formerly known as Ethical Holdings plc, was founded in 1989 and is based in Dublin, Ireland.

Advisors' Opinion:

• [By Brian Orelli]

  2. What's the dose? Patients were given 1 gram of omega-3 fatty acids or an olive oil placebo. One gram isn't a whole lot. The recommended dose for GlaxoSmithKline's (NYSE: GSK  ) prescription-grade fish oil Lovaza is 4 grams. Ditto for Amarin's (NASDAQ: AMRN  ) Vascepa. Omthera Pharmaceuticals' (NASDAQ: OMTH  ) has seen good results with a 2-gram dose of its omega-3 drug Omthera, but that appeared to be due to increased absorption because of the way the drug is prepared.

• [By Brian Orelli]

  Prescriptions of Amarin's (NASDAQ: AMRN  ) Vascepa are on a path to the moon. The company was nice enough to include a graph plotting prescriptions since the lipid-lowering drug launched at the end of January. (You can download a larger version here.)

Hot Low Price Stocks To Watch For 2015: Coldwater Creek Inc. (CWTR)

Coldwater Creek Inc., together with its subsidiaries, operates as a multi-channel specialty retailer of women's apparel, accessories, jewelry, and gift items primarily in the United States. It operates premium retail stores located in traditional malls, lifestyle centers, and street locations; merchandise outlet stores; and day spas, which offer spa treatments, including massages, facials, body treatments, manicures, and pedicures, as well as provide relevant apparel and personal care products. The company also offers its products through its e-commerce Web site coldwatercreek.com and catalogs, as well as through phone and mail. As of October 27, 2012, it operated 354 premium retail stores and 38 factory outlet stores, as well as 9 spas. The company was founded in 1984 and is headquartered in Sandpoint, Idaho.

Advisors' Opinion:

• [By Eric Volkman]

  In turn, it bumps QLogic (NASDAQ: QLGC  ) from that index to the S&P SmallCap 600. Finally, QLogic's shift completely displaces Coldwater Creek (NASDAQ: CWTR  ) , which will no longer be on the S&P SmallCap 600.

• [By Roberto Pedone]

  Another earnings short-squeeze prospect is specialty retailer of women's apparel, accessories, jewelry and gift items Coldwater Creek (CWTR), which is set to release numbers Tuesday after the market close. Wall Street analysts, on average, expect Coldwater Creek to report revenue of $162.81 million on a loss of 63 cents per share.

  The current short interest as a percentage of the float for Coldwater Creek is very high at 18.8%. That means that out of the 12.17 million shares in the tradable float, 3.47 million shares are sold short by the bears. This is a big short interest on a stock with a very low tradable float. If the bulls get the earnings news they're looking for, then this stock could easily explode higher post-earnings.

  From a technical perspective, CWTR is currently trending just below its 50-day moving average and well below its 200-day moving average, which is bearish. This stock has been trending sideways for the last two months, with shares moving between $2.16 on the downside and $2.80 on the upside. A high-volume move above the upper-end of its recent range could trigger a breakout trade for CWTR post-earnings.

  If you're bullish on CWTR, then I would wait until after its report and look for long-biased trades if this stock manages to break out above some near-term overhead resistance levels at $2.51 to $2.69 a share and then once it takes out more resistance at $2.80 a share with high volume. Look for volume on that move that hits near or above its three-month average action of 192,994 shares. If that breakout hits, then CWTR will set up to re-fill some of its previous gap down zone from June that started near $3.60 a share.

  I would simply avoid CWTR or look for short-biased trades if after earnings it fails to trigger that breakout, and then drops back below some key near-term support levels at $2.35 to its 52-week low at $2.16 a share with high volume. If we get that move, then CWTR will set up to enter new 52-wee

• [By Lauren Pollock]

  Coldwater Creek Inc.'s(CWTR) fiscal third-quarter loss widened as the women’s apparel retailer reported a sharp drop in same-store sales and ebbing gross margins. Results missed expectations.

Hot Low Price Stocks To Watch For 2015: Euro/Forint(GY)

GenCorp Inc. engages in the manufacture and sale of aerospace and defense products and systems in the United States. The company operates in two segments, Aerospace and Defense, and Real Estate. The Aerospace and Defense segment offers defense system products, including liquid, solid, and air-breathing propulsion systems and components for applications in missile defense systems, maneuvering propulsion systems, precision war-fighting systems, and specialty metal products, as well as for use in strategic, tactical, and precision strike missiles. This segment also provides composite and metallic aerospace structural components, and warhead and armament systems for precision tactical and long range weapon applications. In addition, it provides liquid, solid, and electric propulsion systems and components for space systems, such as expendable and reusable launch vehicles, transatmospheric vehicles, manned and unmanned spacecraft, separation and maneuvering systems, upper stage engines, satellites, solid boosters, and integrated propulsion subsystems. This segment serves military, civil, and commercial space customers; Department of Defense; National Aeronautics and Space Administration; aerospace, defense, and commercial prime contractors; and various agencies of the United States government. The Real Estate segment engages in the re-zoning, entitlement, sale, and leasing of the company?s excess real estate assets; and owns approximately 12,200 acres of land in the Sacramento metropolitan area. GenCorp Inc. was founded in 1915 and is headquartered in Rancho Cordova, California.

Advisors' Opinion:

• [By Rick Munarriz]

  Monday
  The first trading day of the week kicks off with GenCorp (NYSE: GY  ) posting quarterly results. The aerospace and defense contractor completed its acquisition of Pratt & Whitney's rocket engine manufacturer Rocketdyne after receiving clearance from the Federal Trade Commission earlier this month. Naturally, Rocketdyne's performance won't be baked into the financials.

• [By Jon C. Ogg]

  Short sellers are an interesting lot. They may be betting against the market or against a specific stock, but they are a necessary and useful aspect required for most markets. GenCorp Inc. (NYSE: GY) is a stock that 24/7 Wall St. recently featured as one of nine stocks that could double in 2014. This comes with many risks and caveats, and it also is in direct competition with a massive number of short sellers.

• [By Jake L'Ecuyer]

  Equities Trading DOWN
  Shares of GenCorp (NYSE: GY) were down 5.16 percent to $17.64 after the company reported Q1 results. GenCorp reported a Q1 loss of $0.03 per share.

• [By Jake L'Ecuyer]

  Equities Trading DOWN
  Shares of GenCorp (NYSE: GY) were down 3.97 percent to $17.86 after the company reported Q1 results. GenCorp reported a Q1 loss of $0.03 per share.